Terms: = Skin cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997
44062 results:
1. GZ17-6.02 kills PDX isolates of uveal melanoma.
Booth L; Roberts JL; Spasojevic I; Baker KC; Poklepovic A; West C; Kirkwood JM; Dent P
Oncotarget; 2024 May; 15():328-344. PubMed ID: 38758815
[TBL] [Abstract] [Full Text] [Related]
2. [Application of mixed reality technology in free fibular flap transplantation for repairing mandibular defects].
Song X; Xiang D; Liu D; Liu Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2024 May; 38(5):588-592. PubMed ID: 38752246
[TBL] [Abstract] [Full Text] [Related]
3. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
[TBL] [Abstract] [Full Text] [Related]
4. Enhancing tumor's skin photothermal therapy using Gold nanoparticles : a Monte Carlo simulation.
Zerakni F; Dib ASA; Attili A
Lasers Med Sci; 2024 May; 39(1):130. PubMed ID: 38750285
[TBL] [Abstract] [Full Text] [Related]
5. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract] [Full Text] [Related]
6. Evaluating micronized adipose tissue niche and artificial dermis grafts following nonmelanoma skin cancer excision: a pilot study.
Yun YK; Han SK; Yoon IJ; Namgoong S; Jeong SH; Dhong ES; Kim JH; Lee MC
Wounds; 2024 Apr; 36(4):129-136. PubMed ID: 38743859
[TBL] [Abstract] [Full Text] [Related]
7. Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective.
Kähler KC; Gutzmer R; Angela Y; Livingstone E; Lodde G; Meiss F; Rafei-Shamsabadi DA; Weyer-Fahlbusch SS; Nashan D; Loquai C; Hassel JC; Sachse MMM; Maul LV; Heinzerling L; Heppt MV; Colapietro C; Rusch J; Blome C
J Cancer Res Clin Oncol; 2024 May; 150(5):252. PubMed ID: 38743104
[TBL] [Abstract] [Full Text] [Related]
8. Hospitalization and mortality in Asian autoimmune bullous dermatosis patients: A 17-year retrospective study.
Amonchaisakda N; Rujitharanawong C; Tuchinda P; Kulthanan K; Chularojanamontri L
Exp Dermatol; 2024 May; 33(5):e15095. PubMed ID: 38742822
[TBL] [Abstract] [Full Text] [Related]
9. [Circumscribed choroidal hemangioma and non-pigmented choroidal melanoma: clinical, instrumental and molecular genetic features].
Saakyan SV; Sklyarova NV; Tsygankov AY; Alikhanova VR; Loginov VI; Burdenny AM
Vestn Oftalmol; 2024; 140(2):5-13. PubMed ID: 38742493
[TBL] [Abstract] [Full Text] [Related]
10. Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.
Lin J; Zhu L; Chen Y; Li Q; Ke Z; Zhang H; Huang Y; Lu J; Chen Y
Acta Derm Venereol; 2024 May; 104():adv22146. PubMed ID: 38738772
[TBL] [Abstract] [Full Text] [Related]
11. In Vitro and In Vivo Studies of Melanoma Cell Migration by Antagonistic Mimetics of Adhesion Molecule L1CAM.
Pompili SVB; Fanzini S; Schachner M; Chen S
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732030
[TBL] [Abstract] [Full Text] [Related]
12. Vaccimel immunization is associated with enhanced response to treatment with anti-PD-1 monoclonal antibodies in cutaneous melanoma patients - a case reports study.
Mordoh J; Schwab E; Bravo AI; Aris M; Barrio MM
Front Immunol; 2024; 15():1354710. PubMed ID: 38726010
[TBL] [Abstract] [Full Text] [Related]
13. Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data.
Moser JC; Bhatia S; Amin A; Pavlick AC; Betts KA; Du EX; Poretta T; Shelley K; Srinivasan S; Sakkal LA; Palaia J; Lobo M; Pe Benito M; Linton JA; Chen Y; Xu C; Yin L; Sundar M; Weber J
Cancer Immunol Immunother; 2024 May; 73(7):116. PubMed ID: 38713408
[TBL] [Abstract] [Full Text] [Related]
14. An Explorative Study on Calcium Electroporation for Low-risk Basal Cell Carcinoma.
Wiegell SR; Hendel K; Fuchs CSK; Gehl J; Vissing M; Bro SW; Troelsen JT; Jemec GBE; Haedersdal M
Acta Derm Venereol; 2024 May; 104():adv19678. PubMed ID: 38712969
[TBL] [Abstract] [Full Text] [Related]
15. The Use of Natural Therapies in Patients With skin cancer: A Scoping Review.
Abdin R; Warp PV; Kaiser M; Gaumond SI; Issa NT; Jimenez JJ
J Drugs Dermatol; 2024 May; 23(5):322-326. PubMed ID: 38709697
[TBL] [Abstract] [Full Text] [Related]
16. Postinflammatory Hyperpigmentation Following Mohs Micrographic Surgery: An Observational Study.
Hossain OB; Labiak A; Mieczkowska K; Srikantha R; Ciocon DH; Williams RF
J Drugs Dermatol; 2024 May; 23(5):316-321. PubMed ID: 38709696
[TBL] [Abstract] [Full Text] [Related]
17. Understanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for Melanoma.
Ramirez F; Vasquez R; Gill J; Riva H; Zambrano A; Samaniego M; Fernandez L; Chacon J
J Drugs Dermatol; 2024 May; 23(5):311-315. PubMed ID: 38709695
[TBL] [Abstract] [Full Text] [Related]
18. Influence of Anatomic Locations of T1b Melanomas and Patient Age on Outcomes.
Huang MY; Chen A; Quarshie C; Masson R; Barajas G; Kim G; DeClerck B; Swanson MS; In GK; Kokot N; Pickering TA; Hu JC
J Drugs Dermatol; 2024 May; 23(5):306-310. PubMed ID: 38709694
[TBL] [Abstract] [Full Text] [Related]
19. Beyond the Label: Real-World Side Effects Experienced With FDA-Approved Drugs for Non-Melanoma skin cancers.
Ravipati A; Pradeep T; Nouri K
J Drugs Dermatol; 2024 May; 23(5):301-305. PubMed ID: 38709693
[TBL] [Abstract] [Full Text] [Related]
20. skin Tone Representation on Patient-Facing skin cancer Education Websites.
Sadur A; Nasseri M; McCormick ET; Friedman A
J Drugs Dermatol; 2024 May; 23(5):e137-e138. PubMed ID: 38709691
[TBL] [Abstract] [Full Text] [Related]
[Next]
